bokomslag microRNA: Medical Evidence
Kropp & själ

microRNA: Medical Evidence

Gaetano Santulli

Inbunden

2279:-

Funktionen begränsas av dina webbläsarinställningar (t.ex. privat läge).

Uppskattad leveranstid 10-15 arbetsdagar

Fri frakt för medlemmar vid köp för minst 249:-

Andra format:

  • 429 sidor
  • 2015
This volume explores microRNA function in a wide array of human disorders, providing a clinical basis for precision medicine and personalized therapies using these molecules. The twenty-one chapters, all authored by internationally-renowned experts, open with an introduction contextualizing microRNA manipulation within todays initiatives towards precision medicine. The following chapters explore the clinical role of microRNAs in the diagnosis and treatment of metabolic and cardiovascular disorders, focusing on mitochondrial fitness, arterial hypertension, cardiovascular remodeling, cerebrovascular disease, pulmonary hypertension, diabetic kidney disease, and kidney transplantation. The subsequent chapters discuss the importance of microRNAs in the wound healing process and in skin disease, in the pathogenesis of allergy, in human ovulation, and in infection. The book concludes with chapters which outline the emerging role of microRNAS in doping and detail microRNA profiling. microRNA: Medical Evidence is an ideal companion to both microRNA: Basic Scienceand microRNA: Cancer. Taken together, these three books provide a state-of-the-art overview of this rapidly-expanding and fascinating field, from themolecular level to clinical practice. It will be invaluable to medical students, physicians, and researchers, as a complete and unique guide in the exploration of microRNA in basic science, cancer and clinical practice.
  • Författare: Gaetano Santulli
  • Illustratör: 12 schwarz-weiße Tabellen 8 schwarz-weiße und 19 farbige Abbildungen Bibliographie
  • Format: Inbunden
  • ISBN: 9783319226705
  • Språk: Engelska
  • Antal sidor: 429
  • Utgivningsdatum: 2015-12-21
  • Förlag: Springer International Publishing AG